TT-232

CAS 147159-51-1 0 current records 1 historicalProtein

Who holds supplier records for TT-232? No organisation holds a current US Type II DMF or EU CEP for TT-232 in the registers PharmaTek covers. A further 1 organisation has only historical (inactive) DMF filings.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “TT-232: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/tt-232

Reading the evidence

  • No current DMF or CEP on record

    Only historical filings exist in the covered registers. Any of these organisations may or may not supply today; confirm directly.

Current records (0)

Organisations holding an active US FDA Type II Drug Master File or a CEP for TT-232. Country is the organisation's recorded country, not necessarily the manufacturing site.

Not found in the covered registers (FDA DMF list, EDQM). This is not evidence that no supplier exists.

Need TT-232 sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for TT-232 are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • ORPEGEN PHARMA
    Inactive DMF 21816 · filed Jul 2008

Overview

TT-232 is a protein active pharmaceutical ingredient (ChEMBL CHEMBL539934).

Chemical identity

IUPAC name
(4R,7S,10R,13S,16R)-7-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-16-[[(2R)-2-amino-3-phenylpropanoyl]amino]-13-[(4-hydroxyphenyl)methyl]-10-(1H-indol-3-ylmethyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide
Canonical SMILES
C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC=CC=C5)N)O
InChIKey
SNAJPQVDGYDQSW-DYCFWDQMSA-N
Synonyms
Tln-232, TLN-232, Tt-232, TT 232, TT2-32, D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr(NH2), RefChem:192415, TLN 232, CAP 232, orb1703961, DB12088, DA-58784

Record history

PharmaTek records which organisations hold a current DMF or CEP for TT-232 every week, starting 23 Oct 2026. Additions and lapses will appear here from the next weekly release.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

What do the historical TT-232 records mean?

1 organisation has only inactive Type II DMFs for TT-232. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a TT-232 supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply TT-232?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.